Overview
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
Status:
Withdrawn
Withdrawn
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitisPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alcon Research
Criteria
Inclusion Criteria:- Male and female patients of any race
- 5 years of age and older at the time of the Day 1 visit
- with a primary clinical diagnosis of bacterial conjunctivitis.
Exclusion Criteria:
- Onset of bacterial conjunctivitis (signs and symptoms) more than 4 days
- Presence of punctal plug or punctal occlusion
- Visual Acuity worse than 20/80
- Upper respiratory infection